{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:24:29Z","timestamp":1749813869007,"version":"3.37.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.diabet.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,12,5]],"date-time":"2014-12-05T00:49:16Z","timestamp":1417740556000},"page":"223-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Similar glucose control with basal\u2013bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification"],"prefix":"10.1016","volume":"41","author":[{"given":"R.","family":"Malek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ajili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Assaad-Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2014.11.002_bib0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/dme.12019","article-title":"Stepwise intensification of insulin therapy in type 2 diabetes management \u2013\u00a0exploring the concept of the basal-plus approach in clinical practice","volume":"30","author":"Owens","year":"2013","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"Suppl. 3","key":"10.1016\/j.diabet.2014.11.002_bib0010","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five stages of evolving beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"issue":"5 Suppl.","key":"10.1016\/j.diabet.2014.11.002_bib0015","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.amjmed.2006.01.009","article-title":"Etiology of insulin resistance","volume":"119","author":"Petersen","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.diabet.2014.11.002_bib0020","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2014.11.002_bib0025","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2014.11.002_bib0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/dc10-1710","article-title":"Efficacy of insulin analogs in achieving the hemoglobin\u00a0A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials","volume":"34","author":"Giugliano","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2014.11.002_bib0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1463-1326.2005.00563.x","article-title":"Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70\/30 (the 1-2-3 study)","volume":"8","author":"Garber","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2014.11.002_bib0040","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1001\/jama.289.17.2254","article-title":"Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review","volume":"289","author":"De Witt","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2014.11.002_bib0045","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2337\/dc06-9912","article-title":"Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"29","author":"Nathan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2014.11.002_bib0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/dmrr.733","article-title":"When basal insulin therapy in type 2 diabetes mellitus is not enough \u2013\u00a0what next?","volume":"23","author":"Raccah","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"issue":"9 Suppl. 1","key":"10.1016\/j.diabet.2014.11.002_bib0055","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.amjmed.2013.06.011","article-title":"Intensifying insulin therapy: what options are available to patients with type 2 diabetes?","volume":"126","author":"Meneghini","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.diabet.2014.11.002_bib0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1758-5996-4-50","article-title":"Insulin use, prescription patterns, regimens and costs \u2013\u00a0a narrative from a developing country","volume":"4","author":"Ogbera","year":"2012","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.diabet.2014.11.002_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1002799506855","article-title":"Low vision in Nigerians with diabetes mellitus","volume":"101","author":"Nwosu","year":"2000","journal-title":"Doc Ophthalmol"},{"issue":"Suppl. 4","key":"10.1016\/j.diabet.2014.11.002_bib0070","first-page":"608","article-title":"Frequency of visual impairment and blindness in Congolese people with diabetes","volume":"23","author":"Mvitu","year":"2006","journal-title":"Diabet Med"},{"issue":"Suppl. 1","key":"10.1016\/j.diabet.2014.11.002_bib0075","first-page":"A241","article-title":"Glargine vs. premixed insulin for management of type 2 diabetes patients failing oral antidiabetic drugs: the GALAPAGOS study","volume":"62","author":"Aschner","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2014.11.002_bib0080","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMoa0905479","article-title":"Three-year efficacy of complex insulin regimens in type 2 diabetes","volume":"361","author":"Holman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2014.11.002_bib0085","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1463-1326.2011.01459.x","article-title":"Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month \u2018proof-of-concept\u2019 study","volume":"13","author":"Owens","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2014.11.002_bib0090","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4158\/EP10367.OR","article-title":"Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study","volume":"17","author":"Meneghini","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.diabet.2014.11.002_bib0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/dom.12225","article-title":"Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections","volume":"16","author":"Riddle","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2014.11.002_bib0100","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(12)60205-0","article-title":"Insulin degludec, an ultra-long acting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN basal-bolus type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial","volume":"379","author":"Garber","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2014.11.002_bib0105","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/j.1464-5491.2012.03722.x","article-title":"A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study","volume":"29","author":"Bowering","year":"2012","journal-title":"Diabet Med J Br Diabet Assoc"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363614001761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363614001761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T07:49:57Z","timestamp":1657439397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363614001761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1262363614001761"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2014.11.002","relation":{},"ISSN":["1262-3636"],"issn-type":[{"type":"print","value":"1262-3636"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Similar glucose control with basal\u2013bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}